Bolt Biotherapeutics, Inc. earnings per share and revenue

BOLT earnings per share for the last quarter are -0.40 USD whereas the estimation was -0.34 USD which accounts for -17.65% surprise. Company revenue for the same period amounts to 1.14 M USD despite the estimated figure of 1.25 M USD. Estimated earnings per share for the next quarter are -0.37 USD, and revenue is expected to reach 766.67 k USD. Also watch annual changes over time to get a bigger picture of BOLT earnings per share and revenue dynamics.